Results 81 to 90 of about 146,006 (289)

Oral Glucocorticoid Dose Patterns and Organ Damage in Systemic Lupus Erythematosus—A Nationwide Cohort Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Evaluating the relationship between glucocorticoid (GC) exposure and organ damage in systemic lupus erythematosus (SLE) is challenging because GC dose varies over time. It is unclear which exposure time window captures the full impact of GC usage.
Annica Dominicus   +6 more
wiley   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

ATC at night, 2025

open access: yes
Advanced Technologies Centre (ATC) at night, Hawthorn Campus, 27 March 2025. Taken from the Business and Arts (BA) building on 27 March 2025 using an iPhone, this photo features the Advanced Technologies Centre (ATC) building, recognisable by its ...
Denis Doan
core   +1 more source

GENERAL PRINCIPLES OF SIGNALLING SYSTEMS FOR HIGH SPEED LINES AROUND THE WORLD

open access: yesИнтеллектуальный транспорт
The article deals with the general approaches for construction and today’s trends in development of train control systems for high-speed rail lines, taking into account the data transmission principles, such as cable loops, track circuits and radio, as ...
A. V. Ozerov
doaj  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

ATC Building, 2016

open access: yes, 2016
Images of the Advanced Technologies Centre (ATC) building taken by a camera drone in December ...
Swinburne University of Technology
core   +1 more source

Effects of Cooking on Anthocyanin Concentration and Bioactive Antioxidant Capacity in Glutinous and Non-Glutinous Purple Rice

open access: yesRice Science, 2018
Purple rice is a source of bioactive antioxidants for rice consumers. Loss of the major antioxidant compounds after a range of cooking processes was evaluated by measuring the changes in anthocyanin concentration (ATC) and antioxidant capacity (DPPH ...
Supaporn Yamuangmorn   +2 more
doaj   +1 more source

Impurity concentration in the ATC [PDF]

open access: yes, 1973
The impurity level in the ATC before compression was investigated by spectroscopic measurements. The first experimental results concerning the concentrations and the influence of impurities on some discharge characteristics are given. (auth)
openaire   +2 more sources

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

ATC steps at night, 2011

open access: yes, 2011
Advanced Technologies Centre (ATC) grass steps at night, Hawthorn Campus, 10 June ...
Andrew Sampson
core   +1 more source

Home - About - Disclaimer - Privacy